Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.
Copyright 2019 - 2024. MjInvest.com and MjMicro Cap are divisions of MjLink.com, Inc.. All rights reserved. MjInvest
Legal Disclaimer - https://www.mjinvest.com/legal-disclaimer
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law:
You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
